Default company panoramic image

Pandora Genomics

Your DNA affects which drugs work for you. Pandora Genomics matches your DNA to the right medications, saving both time and money.

  • Stage Prototype Ready
  • Industry Software
  • Location Orlando, FL, USA
  • Currency USD
  • Founded May 2011
  • Employees 3
  • Website

Company Summary

Pandora Genomics is a medical informatics company. The company provides comprehensive molecular testing and data analysis solutions to address two costly issues in the healthcare industry: ineffective medications and adverse drug reactions in patients. Pandora Genomics develops analytical software, biological assays, and proprietary platform technology.


  • Default avatar
    Melissa H Kuchma
    Chief Operating Officer

    Dr. Kuchma earned her PhD in Chemistry from the Massachusetts Institute of Technology, where her research focused on radiopharmaceutical design and synthesis in conjunction with Harvard Medical School. She worked on biological applications of nanotechnology at the UCF NanoScience Technology Center, including the use of microfluidics in medical devices. Prior to founding Pandora Genomics, she was a faculty member at MD Anderson Cancer Center.

  • Default avatar
    Philip A Arlen
    Chief Scientific Officer

    Dr. Arlen earned a BS in Biology from Cornell University and PhD in Microbiology, Immunology, and Molecular Genetics from the University of California, Los Angeles. His work has focused on genomic variations, gene expression patterns, and the discovery of other biomarkers that are associated with clinical responses to therapy. Prior to founding Pandora Genomics, he was a faculty member at MD Anderson Cancer Center.

  • Default avatar
    David K Smith
    Chief Medical Officer

    Dr. Smith brings more than 40 years of medical experience to Pandora Genomics. After founding and managing his own successful hematology and oncology practice, he became Medical Director for the design and build phases of Florida Hospital’s successful electronic medical record (EMR) implementation. He is Board Certified by the American Board of Internal Medicine in the subspecialty of Medical Oncology.


  • Default avatar
    Edwin Flores, JD, PhD, Partner, Chalker Flores, LLP
    Default avatar
    Jim Cross, CPA, Managing Partner, Cross, Fernandez and Riley, LLP

Previous Investors

  • Default avatar